Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $133000.0.

  • Bolt Biotherapeutics' Other Non-Current Liabilities changed N/A to $133000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $133000.0, marking a year-over-year change of. This contributed to the annual value of $43000.0 for FY2023, which is 238.1% up from last year.
  • Bolt Biotherapeutics' Other Non-Current Liabilities amounted to $133000.0 in Q3 2025.
  • In the past 5 years, Bolt Biotherapeutics' Other Non-Current Liabilities ranged from a high of $321000.0 in Q1 2021 and a low of $42000.0 during Q4 2022
  • Moreover, its 4-year median value for Other Non-Current Liabilities was $133000.0 (2025), whereas its average is $146466.7.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 8000.0% in 2022, then surged by 238.1% in 2023.
  • Quarter analysis of 4 years shows Bolt Biotherapeutics' Other Non-Current Liabilities stood at $210000.0 in 2021, then crashed by 80.0% to $42000.0 in 2022, then grew by 2.38% to $43000.0 in 2023, then skyrocketed by 209.3% to $133000.0 in 2025.
  • Its Other Non-Current Liabilities stands at $133000.0 for Q3 2025, versus $133000.0 for Q2 2025 and $132000.0 for Q1 2025.